PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes (Q46961428)

26 December 2017

title

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes (English)

1 reference

26 December 2017

1 reference

4

Jean-Pierre Després

1 reference

26 December 2017

Ilse Mertens

1

1 reference

26 December 2017

Isabelle Lemieux

series ordinal

2

1 reference

26 December 2017

An Verrijken

series ordinal

3

1 reference

26 December 2017

Luc F Van Gaal

series ordinal

5

1 reference

26 December 2017

publication date

1 February 2008

1 reference

26 December 2017

Diabetes - Metabolism: Research and Reviews

published in

1 reference

26 December 2017

volume

24

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

141-147

1 reference

26 December 2017

LDL size and risk of coronary heart disease in elderly men and women

cites work

1 reference

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

21 January 2018

1 reference

LDL subclass phenotypes and the insulin resistance syndrome in women.

21 January 2018

1 reference

Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study

21 January 2018

1 reference

Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

21 January 2018

1 reference

Hypertriglyceridemia and regulation of fibrinolytic activity

21 January 2018

1 reference

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

21 January 2018

1 reference

7 January 2021

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

7 January 2021

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study

1 reference

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

7 January 2021

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

1 reference

7 January 2021

LDL size and subclass pattern in a biethnic population.

1 reference

7 January 2021

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

1 reference

7 January 2021

LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study

1 reference

7 January 2021

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

1 reference

7 January 2021

Greater effect of diabetes on LDL size in women than in men.

1 reference

7 January 2021

Effect of type 2 diabetes on various electrophoretic characteristics of low-density lipoprotein particles in women

1 reference

7 January 2021

Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.

1 reference

7 January 2021

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Obesity, haemostasis and the fibrinolytic system

1 reference

7 January 2021

Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men

1 reference

7 January 2021

Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women

1 reference

7 January 2021

Prothrombotic markers in familial combined hyperlipidemiaEvidence of endothelial cell activation and relation to metabolic syndrome

1 reference

7 January 2021

Assessment of fat-free mass using bioelectrical impedance measurements of the human body.

1 reference

7 January 2021

Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study

1 reference

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

7 January 2021

Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins

1 reference

7 January 2021

Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein

1 reference

7 January 2021

Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects

1 reference

7 January 2021

Small, dense low-density-lipoproteins and the metabolic syndrome.

1 reference

7 January 2021

Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells

1 reference

7 January 2021

Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.779

1 reference

26 December 2017

PubMed ID

17922472

1 reference

26 December 2017